March 2026 Eurosets S.r.l. officially commenced U.S. commercialization of its Trilly and Horizon oxygenator systems following FDA 510(k) clearance and entered a strategic distribution partnership with Orion Medical to expand access to its cardiopulmonary bypass oxygenator portfolio in the U.S. market.
December 2025 Eurosets S.r.l. received U.S. FDA 510(k) clearance for its Horizon AF Plus System (including the A.L. One AF Plus Oxygenator), expanding its cardiopulmonary bypass oxygenator portfolio for cardiac surgery applications.
May 2025 MC3 Inc. continued expanding commercialization of its Nautilus VF ECMO Oxygenator following U.S. FDA clearance, supporting long-term extracorporeal membrane oxygenation (ECMO) applications and strengthening its advanced oxygenator product portfolio.